Status:
WITHDRAWN
A Multidisciplinary Perioperative Pain Management
Lead Sponsor:
China-Japan Friendship Hospital
Conditions:
Anorectal Surgery
Pain Management
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Objective: This study aimed to evaluate the clinical value of a multidisciplinary collaboration (MDC)-based perioperative pain management model. Methods: A prospective, randomized controlled trial was...
Eligibility Criteria
Inclusion
- Age ≥18 years (adult patients capable of cooperating with assessments and interventions; pediatric patients were excluded due to developmental differences in pain perception and response);
- No severe anal malformations (defined as conditions that could significantly alter surgical technique or affect wound healing, such as anal stenosis or grade III or higher rectal prolapse) and no history of previous anal surgery;
- Complete clinical data available;
- Clear consciousness and intact cognitive and communication abilities, with the capacity to comply with study assessments and interventions;
- Diagnosis of a common benign anorectal disease requiring elective surgery (e.g., grade III/IV mixed hemorrhoids, simple anal fistula, chronic anal fissure, low perianal abscess) in accordance with the diagnostic criteria outlined in the Guideline for Clinical Diagnosis and Treatment of Hemorrhoids (2017 edition).
Exclusion
- Diagnosis of inflammatory bowel disease, colorectal malignancy, or active intestinal infection; presence of significant dysfunction in major organs (e.g., ASA \[American Society of Anesthesiologists\] physical status classification ≥ III), autoimmune diseases, or long-term use of immunosuppressants or corticosteroids;
- History of chronic pain syndromes or long-term use of opioid analgesics;
- Presence of moderate-to-severe lumbar spinal disease or deformity that precludes neuraxial anesthesia (e.g., planned spinal anesthesia);
- Withdrawal from the study or incomplete clinical data;
- History of psychiatric disorders or cognitive impairment rendering the patient unable to comply with assessments.
Key Trial Info
Start Date :
July 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 10 2024
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT07150819
Start Date
July 1 2022
End Date
December 10 2024
Last Update
December 19 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
China-Japan Friendship Hospita
Beijing, Beijing City, China, 100029